LINC01016 and breast cancer: We next modulated the expression levels of LINC01016 in two BC cell lines (MDA-MB-231 and MDA-MB-468) using ASO and PCDNA3.1-LINC01016 vector constructs to achieve lncRNA knockdown and overexpression, respectively, with the efficiency confirmed via qRT-PCR (Supplementary Fig. 1B, C and Supplementary Fig. 3A).